734 related articles for article (PubMed ID: 26323631)
1. Xenobiotics: Interaction with the Intestinal Microflora.
Lu K; Mahbub R; Fox JG
ILAR J; 2015; 56(2):218-27. PubMed ID: 26323631
[TBL] [Abstract][Full Text] [Related]
2. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson HI
Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
[TBL] [Abstract][Full Text] [Related]
3. Human gut microbiota plays a role in the metabolism of drugs.
Jourova L; Anzenbacher P; Anzenbacherova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
[TBL] [Abstract][Full Text] [Related]
4. Chemical transformation of xenobiotics by the human gut microbiota.
Koppel N; Maini Rekdal V; Balskus EP
Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
[TBL] [Abstract][Full Text] [Related]
5. Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism.
Dikeocha IJ; Al-Kabsi AM; Miftahussurur M; Alshawsh MA
FASEB J; 2022 Jun; 36(6):e22350. PubMed ID: 35579628
[TBL] [Abstract][Full Text] [Related]
6. [Intestinal microbiota].
Debré P; Le Gall JY;
Bull Acad Natl Med; 2014 Dec; 198(9):1667-84. PubMed ID: 27356369
[TBL] [Abstract][Full Text] [Related]
7. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
Rosenfeld CS
Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
[TBL] [Abstract][Full Text] [Related]
8. Connecting the dots: Targeting the microbiome in drug toxicity.
Luo Y; Zhou T
Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
[TBL] [Abstract][Full Text] [Related]
9. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
[TBL] [Abstract][Full Text] [Related]
10. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
11. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
[TBL] [Abstract][Full Text] [Related]
12. Chemical Metabolism of Xenobiotics by Gut Microbiota.
Nakov R; Velikova T
Curr Drug Metab; 2020; 21(4):260-269. PubMed ID: 32124693
[TBL] [Abstract][Full Text] [Related]
13. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
[TBL] [Abstract][Full Text] [Related]
15. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids.
Fu J; Bonder MJ; Cenit MC; Tigchelaar EF; Maatman A; Dekens JA; Brandsma E; Marczynska J; Imhann F; Weersma RK; Franke L; Poon TW; Xavier RJ; Gevers D; Hofker MH; Wijmenga C; Zhernakova A
Circ Res; 2015 Oct; 117(9):817-24. PubMed ID: 26358192
[TBL] [Abstract][Full Text] [Related]
16. Influence of the human intestinal microbiome on obesity and metabolic dysfunction.
Tilg H; Adolph TE
Curr Opin Pediatr; 2015 Aug; 27(4):496-501. PubMed ID: 26087428
[TBL] [Abstract][Full Text] [Related]
17. Cross-regulatory Circuit Between AHR and Microbiota.
Ji J; Qu H
Curr Drug Metab; 2019; 20(1):4-8. PubMed ID: 29380692
[TBL] [Abstract][Full Text] [Related]
18. The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps.
Sutherland VL; McQueen CA; Mendrick D; Gulezian D; Cerniglia C; Foley S; Forry S; Khare S; Liang X; Manautou JE; Tweedie D; Young H; Alekseyenko AV; Burns F; Dietert R; Wilson A; Chen C
Toxicol Sci; 2020 Jul; 176(1):1-10. PubMed ID: 32658296
[TBL] [Abstract][Full Text] [Related]
19. The Gut Microbiota Impact Cancer Etiology through "Phase IV Metabolism" of Xenobiotics and Endobiotics.
Ervin SM; Redinbo MR
Cancer Prev Res (Phila); 2020 Aug; 13(8):635-642. PubMed ID: 32611614
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
Schulberg J; De Cruz P
Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
